Literature DB >> 33407472

Resistin-like molecule β acts as a mitogenic factor in hypoxic pulmonary hypertension via the Ca2+-dependent PI3K/Akt/mTOR and PKC/MAPK signaling pathways.

Heshen Tian1,2, Lei Liu1, Ying Wu1, Ruiwen Wang1, Yongliang Jiang1, Ruicheng Hu1, Liming Zhu1, Linwei Li1, Yanyan Fang1, Chulan Yang1, Lianzhi Ji1, Guoyu Liu1, Aiguo Dai3,4.   

Abstract

BACKGROUND: Pulmonary arterial smooth muscle cell (PASMC) proliferation plays a crucial role in hypoxia-induced pulmonary hypertension (HPH). Previous studies have found that resistin-like molecule β (RELM-β) is upregulated de novo in response to hypoxia in cultured human PASMCs (hPASMCs). RELM-β has been reported to promote hPASMC proliferation and is involved in pulmonary vascular remodeling in patients with PAH. However, the expression pattern, effects, and mechanisms of action of RELM-β in HPH remain unclear.
METHODS: We assessed the expression pattern, mitogenetic effect, and mechanism of action of RELM-β in a rat HPH model and in hPASMCs.
RESULTS: Overexpression of RELM-β caused hemodynamic changes in a rat model of HPH similar to those induced by chronic hypoxia, including increased mean right ventricular systolic pressure (mRVSP), right ventricular hypertrophy index (RVHI) and thickening of small pulmonary arterioles. Knockdown of RELM-β partially blocked the increases in mRVSP, RVHI, and vascular remodeling induced by hypoxia. The phosphorylation levels of the PI3K, Akt, mTOR, PKC, and MAPK proteins were significantly up- or downregulated by RELM-β gene overexpression or silencing, respectively. Recombinant RELM-β protein increased the intracellular Ca2+ concentration in primary cultured hPASMCs and promoted hPASMC proliferation. The mitogenic effects of RELM-β on hPASMCs and the phosphorylation of PI3K, Akt, mTOR, PKC, and MAPK were suppressed by a Ca2+ inhibitor.
CONCLUSIONS: Our findings suggest that RELM-β acts as a cytokine-like growth factor in the development of HPH and that the effects of RELM-β are likely to be mediated by the Ca2+-dependent PI3K/Akt/mTOR and PKC/MAPK pathways.

Entities:  

Keywords:  Ca2+; Hypoxic pulmonary arterial hypertension; Pulmonary vascular remodeling; Resistin-like molecule β; SOCE; Signaling pathway

Year:  2021        PMID: 33407472     DOI: 10.1186/s12931-020-01598-4

Source DB:  PubMed          Journal:  Respir Res        ISSN: 1465-9921


  42 in total

Review 1.  Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension.

Authors:  Ming-xing Li; De-qi Jiang; Yan Wang; Qing-zhuang Chen; Yan-jiao Ma; Shan-shan Yu; Yong Wang
Journal:  J Cardiovasc Pharmacol       Date:  2016-02       Impact factor: 3.105

Review 2.  Pulmonary hypertension in chronic obstructive pulmonary disease and emphysema patients: prevalence, therapeutic options and pulmonary circulatory effects of lung volume reduction surgery.

Authors:  Isabelle Opitz; Silvia Ulrich
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

3.  Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2.

Authors:  Kazuyo Yamaji-Kegan; Qingning Su; Daniel J Angelini; Hunter C Champion; Roger A Johns
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08-04       Impact factor: 5.464

4.  A family of tissue-specific resistin-like molecules.

Authors:  C M Steppan; E J Brown; C M Wright; S Bhat; R R Banerjee; C Y Dai; G H Enders; D G Silberg; X Wen; G D Wu; M A Lazar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

Review 5.  Evaluation and classification of pulmonary arterial hypertension.

Authors:  Sandeep Sahay
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

6.  Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension.

Authors:  A Campo; S C Mathai; J Le Pavec; A L Zaiman; L K Hummers; D Boyce; T Housten; N Lechtzin; H Chami; R E Girgis; P M Hassoun
Journal:  Eur Respir J       Date:  2011-02-10       Impact factor: 16.671

Review 7.  Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.

Authors:  Kurt R Stenmark; Karen A Fagan; Maria G Frid
Journal:  Circ Res       Date:  2006-09-29       Impact factor: 17.367

8.  FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties.

Authors:  Xingwu Teng; Dechun Li; Hunter C Champion; Roger A Johns
Journal:  Circ Res       Date:  2003-04-24       Impact factor: 17.367

9.  Comparative studies of resistin expression and phylogenomics in human and mouse.

Authors:  Rong-Ze Yang; Qing Huang; Aihua Xu; John C McLenithan; Jonathan A Eisen; Alan R Shuldiner; Serhan Alkan; Da-Wei Gong; Jonathan A Eison
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

Review 10.  The Critical Role of Pulmonary Arterial Compliance in Pulmonary Hypertension.

Authors:  Thenappan Thenappan; Kurt W Prins; Marc R Pritzker; John Scandurra; Karl Volmers; E Kenneth Weir
Journal:  Ann Am Thorac Soc       Date:  2016-02
View more
  8 in total

Review 1.  Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.

Authors:  Helen Christou; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-25       Impact factor: 4.733

2.  MonOrail to Cure? Targeting Orai1 to Reverse Pulmonary Arterial Hypertension.

Authors:  Tatiana V Kudryashova; Elena A Goncharova
Journal:  Circ Res       Date:  2022-10-13       Impact factor: 23.213

3.  Inhibition of KIF23 Alleviates IPAH by Targeting Pyroptosis and Proliferation of PASMCs.

Authors:  Zeang Wu; Guangyuan Zhou; Haixia Wang; Ping Yao
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

4.  The variations in human orphan G protein-coupled receptor QRFPR affect PI3K-AKT-mTOR signaling.

Authors:  Huanzheng Li; Ran Lou; Xueqin Xu; Chenyang Xu; Yuan Yu; Yunzhi Xu; Lin Hu; Yanbao Xiang; Xuan Lin; Shaohua Tang
Journal:  J Clin Lab Anal       Date:  2021-05-21       Impact factor: 2.352

5.  Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.

Authors:  Mingzhou Guo; Mengzhe Zhang; Xiaopei Cao; Xiaoyu Fang; Ke Li; Lu Qin; Yuanzhou He; Jianping Zhao; Yongjian Xu; Xiansheng Liu; Xiaochen Li
Journal:  Respir Res       Date:  2022-01-11

6.  The Inflammatory Response Induced by RELMβ Upregulates IL-8 and IL-1β Expression in Bronchial Epithelial Cells in COPD.

Authors:  Li Che; Chao Yu; Guangshu Chen; Jiaxin Lin; Zhefan Xie; Tingting Xia; Wenzhi Luo; Xingdong Cai; Shengming Liu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-09-02

7.  Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension.

Authors:  Jingjing Zhou; FuRong Li; Yicheng Yang
Journal:  Respir Res       Date:  2022-08-30

8.  Integrated analysis of m6A mRNA methylation in rats with monocrotaline-induced pulmonary arterial hypertension.

Authors:  Yunhong Zeng; Ting Huang; Wanyun Zuo; Dan Wang; Yonghui Xie; Xun Wang; Zhenghui Xiao; Zhi Chen; Qiming Liu; Na Liu; Yunbin Xiao
Journal:  Aging (Albany NY)       Date:  2021-07-26       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.